Generic Name and Formulations:
Diclofenac sodium 3%; gel; contains benzyl alcohol.
Indications for SOLARAZE:
Use lowest effective dose for shortest duration. Apply to lesions twice daily for 60–90 days.
Coronary artery bypass graft surgery.
Risk of serious cardiovascular events.
Increased risk of serious cardiovascular events (including MI, stroke). Avoid in recent MI, severe heart failure; if necessary, monitor. History of ulcer disease and/or GI bleeding. Severe renal or hepatic impairment. Avoid sun and UV light. Aspirin allergy. Asthma. Avoid eyes, and open skin wounds, infections, or exfoliative dermatitis. Elderly. Labor & delivery. Pregnancy (Cat.B); avoid in 3rd trimester. Nursing mothers: not recommended.
Increased risk of GI events with concomitant aspirin or oral NSAIDs. Concomitant other topical medications or products (eg, sunscreens, cosmetics): not studied.
Pruritus, rash, contact dermatitis, dry skin, exfoliation, local pain, paresthesia; cardiovascular thrombotic events, edema, photosensitivity.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL